News

NEWS

2024-11-26 15:49

…the Biotech company myriamed GmbH is located in this inconspicuous building not far from the Universitätsmedizin Göttingen and the Sartorius Campus.

2024-11-26 15:49
2024-11-20 16:18

3D human tissue models are gaining popularity and are becoming more and more the focus of science and, not least, the pharmaceutical industry.

2024-11-20 16:18
2024-07-10 12:52

We had inspiring conversations with customers, business partners and interested parties for our myriamed GmbH product pipeline.

2024-07-10 12:52
2024-07-02 18:36

myriamed and SYNENTEC are proud to unveil the myrImager - a groundbreaking platform for high-content-analysis of pluripotent stem cell-derived heart muscle, skeletal muscle and connective tissue.

2024-07-02 18:36
2024-06-26 12:40

Come and join Eriona Heta, PhD , Dr. Aleks G. and Arne Östlind from myriamed GmbH and SYNENTEC tomorrow at booth 615 on the ISSCR in Hamburg!

2024-06-26 12:40
2024-06-05 15:19

myriamed GmbH's ultimate aim is to contribute to the development of new cures for today‘s most debilitating diseases by defining wanted and…

2024-06-05 15:19
2023-10-09 11:54

Can hearts and heart muscle be repaired? What role do pluripotent stem cells play in this? And how could the same technology also produce artificial flesh on a massive scale?

2023-10-09 11:54
2023-09-27 10:01

At the SPS Meeting Developer Tim Meyer of the myriamed GmbH presents a preview of its brand new MyrImager!

2023-09-27 10:01
2023-06-20 16:16

…and 3D organoids offer potential solutions to some of these challenges. Here are a few key challenges and how 3D organoids can help address them.

2023-06-20 16:16
Copyright 2024 Seaside Media. All Rights Reserved.
<defs> </defs>